Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy L Cho

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Gland Surgery|August 23, 2024
Opportunities to improve the diagnosis and treatment of primary hyperparathyroidism: retrospective cohort studyMatthew P Vivero, Yu-Jen Chen, Alexis G Antunez, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 18, 2018
Chemopreventive Efficacy of the Cyclooxygenase-2 (Cox-2) Inhibitor, Celecoxib, Is Predicted by Adenoma Expression of Cox-2 and 15-PGDHJiping Wang, Nancy L Cho, Ann G Zauber, et al.
Surgery|December 6, 2011
Necroptosis is a novel mechanism of radiation-induced cell death in anaplastic thyroid and adrenocortical cancersMatthew A Nehs, Chi-Iou Lin, David E Kozono, et al.
The Journal of Surgical Research|July 15, 2025
Streamlining Health Care Access for Patients With Primary Hyperparathyroidism: A Quality Improvement Pilot ProgramNora O Sheu, Stefanie J Soelling, Jake A Awtry, et al.
The Journal of Clinical Endocrinology and Metabolism|February 13, 2024
Nonoperative, Active Surveillance of Larger Malignant and Suspicious Thyroid NodulesBenjamin Altshuler, Athanasios Bikas, Theodora Pappa, et al.
Thyroid : Official Journal of the American Thyroid Association|November 4, 2020
Papillary Thyroid Carcinoma with High-Grade Features Versus Poorly Differentiated Thyroid Carcinoma: An Analysis of Clinicopathologic and Molecular Features and OutcomeKristine S Wong, Fei Dong, Milhan Telatar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 2023
Additional Oncogenic Alterations in RAS-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic OutcomesAthanasios Bikas, Sara Ahmadi, Theodora Pappa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2021
Oncogenic Mutations in PI3K/AKT/mTOR Pathway Effectors Associate with Worse Prognosis in <i>BRAF</i> -Driven Papillary Thyroid Cancer PatientsTheodora Pappa, Sara Ahmadi, Ellen Marqusee, et al.
Histopathology|December 8, 2019
A potential diagnostic pitfall for hobnail variant of papillary thyroid carcinomaKristine S Wong, Tiffany Y Chen, Sara E Higgins, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
Aberrant crypt foci in the adenoma prevention with celecoxib trialNancy L Cho, Mark Redston, Ann G Zauber, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Gland Surgery|August 23, 2024
Opportunities to improve the diagnosis and treatment of primary hyperparathyroidism: retrospective cohort studyMatthew P Vivero, Yu-Jen Chen, Alexis G Antunez, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 18, 2018
Chemopreventive Efficacy of the Cyclooxygenase-2 (Cox-2) Inhibitor, Celecoxib, Is Predicted by Adenoma Expression of Cox-2 and 15-PGDHJiping Wang, Nancy L Cho, Ann G Zauber, et al.
Surgery|December 6, 2011
Necroptosis is a novel mechanism of radiation-induced cell death in anaplastic thyroid and adrenocortical cancersMatthew A Nehs, Chi-Iou Lin, David E Kozono, et al.
The Journal of Surgical Research|July 15, 2025
Streamlining Health Care Access for Patients With Primary Hyperparathyroidism: A Quality Improvement Pilot ProgramNora O Sheu, Stefanie J Soelling, Jake A Awtry, et al.
The Journal of Clinical Endocrinology and Metabolism|February 13, 2024
Nonoperative, Active Surveillance of Larger Malignant and Suspicious Thyroid NodulesBenjamin Altshuler, Athanasios Bikas, Theodora Pappa, et al.
Thyroid : Official Journal of the American Thyroid Association|November 4, 2020
Papillary Thyroid Carcinoma with High-Grade Features Versus Poorly Differentiated Thyroid Carcinoma: An Analysis of Clinicopathologic and Molecular Features and OutcomeKristine S Wong, Fei Dong, Milhan Telatar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 2023
Additional Oncogenic Alterations in RAS-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic OutcomesAthanasios Bikas, Sara Ahmadi, Theodora Pappa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2021
Oncogenic Mutations in PI3K/AKT/mTOR Pathway Effectors Associate with Worse Prognosis in <i>BRAF</i> -Driven Papillary Thyroid Cancer PatientsTheodora Pappa, Sara Ahmadi, Ellen Marqusee, et al.
Histopathology|December 8, 2019
A potential diagnostic pitfall for hobnail variant of papillary thyroid carcinomaKristine S Wong, Tiffany Y Chen, Sara E Higgins, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
Aberrant crypt foci in the adenoma prevention with celecoxib trialNancy L Cho, Mark Redston, Ann G Zauber, et al.
Pageof 8